RevolKa is a biotechnology firm that manufactures bio-products pharmaceuticals intended to serve the healthcare sector.
RevolKa has raised $376K in total funding. The most recent round was Grant. The last funding was announced in June 2025.
RevolKa's investors include Deepcore, Aerion Partners, AMED, Tohoku University Venture Partners, D3.
RevolKa is headquartered in Sendai, Japan.
RevolKa is a biotechnology firm that manufactures bio-products pharmaceuticals intended to serve the healthcare sector.
RevolKa is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RevolKa — Funding & Investors." VCBacked, June 30, 2025, https://www.vcbacked.co/company/revolka. Accessed August 14, 2026.
VCBacked. (2025). RevolKa — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/revolka
{{cite web |title=RevolKa — Funding & Investors |url=https://www.vcbacked.co/company/revolka |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated